Programme

Session 1 - The translation barrier: problems and solutions in moving from animal models to clinical trials

Sanjiv Sam Gambhir, Stanford University
Harvey Herschman, University of California, Los Angeles
Vasilis Ntziachristos, Institute for Biological and Medical Imaging
Antoni Ribas, University of California, Los Angeles
Wolfgang Weber, University Medical Center Freiburg

Session 2 - The potential clinical use of MRS in oncology

Patrick Bolan, University of Minnesota
Ferdia Gallagher, Cancer Research UK Cambridge Research Institute
Ingrid Gribbestad, Norwegian University of Science and Technology
Arend Heerschap, Radboud University Nijmegen Medical Center
Sarah Nelson, UCSF Helen Diller Family Comprehensive Cancer Center

Session 3 - Detecting genomic biomarkers from high-dimensional clinical data

Nicholas Dracopoli, Johnson & Johnson
Joseph Lucas, Duke Institute for Genome Sciences and Policy
Jill Mesirov, Broad Institute of MIT and Harvard
Eric Schadt, Pacific Biosciences
Rainer Spang, University of Regensburg

Session 4 - Opportunities of preneoplasia for a pre-emptive strike

Rebecca Fitzgerald, Hutchison-MRC Research Centre
Carlo Maley, The Wistar Institute
Sanford Markowitz, Case Western Reserve University
Senthil Muthuswamy, Cold Spring Harbor Laboratory
Nicholas Wright, Cancer Research UK London Research Institute and the Barts and the London School of Medicine and Dentistry

Deadline for registration - 31 January 2010

Feedback